STOCK TITAN

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

ORIC (Nasdaq: ORIC) announced management will participate in three investor conferences in February 2026 with fireside chats and one-on-one meetings.

Schedule: Guggenheim Emerging Outlook: Biotech Summit on Feb 12 at 10:30 a.m. ET; Citi Virtual Oncology Leadership Summit on Feb 18 at 2:30 p.m. ET; Oppenheimer Healthcare Life Sciences on Feb 25 at 12:00 p.m. ET. Webcasts and 90-day replays will be available via the company's investor website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that management will be participating in the following investor conferences in February:

  • Guggenheim Emerging Outlook: Biotech Summit – Participating in a fireside chat on Thursday, February 12, 2026, at 10:30 a.m. ET. Management will also be participating in one-on-one meetings.

  • Citi’s 2026 Virtual Oncology Leadership Summit – Participating in a fireside chat on Wednesday, February 18, 2026, at 2:30 p.m. ET. Management will also be participating in one-on-one meetings.

  • Oppenheimer 36th Annual Healthcare Life Sciences – Participating in a fireside chat on Wednesday, February 25, 2026, at 12:00 p.m. ET. Management will also be participating in one-on-one meetings.

Webcasts of the fireside chat discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.

About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) rinzimetostat (ORIC-944), an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib, a brain-penetrant inhibitor targeting EGFR exon 20 and PACC mutations, being developed for NSCLC. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.

Contact:

Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com


FAQ

When will ORIC (ORIC) present at the Guggenheim Emerging Outlook: Biotech Summit in February 2026?

ORIC will present a fireside chat on Thursday, February 12, 2026 at 10:30 a.m. ET. According to ORIC, management will also hold one-on-one meetings and a webcast will be available via the investor website with replay access for 90 days.

What is the date and time for ORIC's fireside chat at Citi’s 2026 Virtual Oncology Leadership Summit?

ORIC's fireside chat is scheduled for Wednesday, February 18, 2026 at 2:30 p.m. ET. According to ORIC, management will conduct one-on-one meetings and the event webcast will be posted on the investor site with a 90-day replay window.

How can investors watch ORIC's fireside chats and for how long will replays be available?

Investors can watch live webcasts through ORIC's investor website, with replays available for 90 days after each event. According to ORIC, webcasts for the February fireside chats will be posted on the company's investor section for on-demand viewing.

When is ORIC scheduled to participate at Oppenheimer 36th Annual Healthcare Life Sciences in February 2026?

ORIC will participate in a fireside chat on Wednesday, February 25, 2026 at 12:00 p.m. ET. According to ORIC, management will also hold one-on-one meetings and the fireside chat webcast will be accessible via the investor website with a 90-day replay.

Will ORIC management hold meetings beyond fireside chats during the February 2026 conferences?

Yes, ORIC management will hold one-on-one investor meetings in addition to scheduled fireside chats at each conference. According to ORIC, these meetings are planned alongside the Feb 12, Feb 18, and Feb 25 fireside chat events and related webcasts.
Oric Pharmaceuticals, Inc.

NASDAQ:ORIC

ORIC Rankings

ORIC Latest News

ORIC Latest SEC Filings

ORIC Stock Data

1.03B
87.10M
6.94%
99.21%
8.42%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO